One 2 One has a wealth of history and experience in global parenteral commercialization. As a service of Hospira, One 2 One was created from the global hospital products business of Abbott Laboratories and has successfully produced and launched hundreds of sterile injectables.

Our history and accomplishments contribute to your comfort zone

• 80+ years of manufacturing biologics and small molecules
  • Filling over 25 different monoclonal antibodies, proteins, peptides and recombinant vaccines, 16 of which are commercial products
  • 25 dispersed system formulations and 11 cytotoxic products
  • Over 10 cephalosporin, penicillin and penen products
• Practical knowledge of 70 markets
  • Including expert, international regulatory filing strategies for the Americas, Europe, Asia Pacific and ROW
• Seamlessly coordinated, centralized system for global decision-making and commercialization strategies, infused with local expertise
  • Orchestrates nine parenteral facilities for synergy of services
• Personalized service and attention to the unique needs of each client

With highly qualified personnel in every worldwide, world-class facility, One 2 One can ensure extraordinary quality, capacity, and security of supply.

View the Current One 2 One Brochure

See the keys to commercialization success